HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fanconi Syndrome (Syndrome, Fanconi)

A hereditary or acquired form of generalized dysfunction of the PROXIMAL KIDNEY TUBULE without primary involvement of the KIDNEY GLOMERULUS. It is usually characterized by the tubular wasting of nutrients and salts (GLUCOSE; AMINO ACIDS; PHOSPHATES; and BICARBONATES) resulting in HYPOKALEMIA; ACIDOSIS; HYPERCALCIURIA; and PROTEINURIA.
Also Known As:
Syndrome, Fanconi; Fanconi Renotubular Syndrome; Idiopathic De Toni-Debre-Fanconi Syndrome; Neonatal De Toni-Debre-Fanconi Syndrome; Primary Toni-Debre-Fanconi Syndrome; Toni-Debre-Fanconi Syndrome; De Toni Debre Fanconi Syndrome; Idiopathic De Toni Debre Fanconi Syndrome; Lignac Fanconi Syndrome; Neonatal De Toni Debre Fanconi Syndrome; Primary Toni Debre Fanconi Syndrome; Syndrome, De Toni-Debre-Fanconi; Syndrome, Fanconi Renotubular; Syndrome, Lignac-Fanconi; Toni Debre Fanconi Syndrome; Toni-Debre-Fanconi Syndrome, Primary; De Toni-Debre-Fanconi Syndrome; Lignac-Fanconi Syndrome; Proximal Renal Tubular Dysfunction; Renal Fanconi Syndrome
Networked: 387 relevant articles (8 outcomes, 26 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1. Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
2. Glycosuria
3. Cystinosis
4. Hypophosphatemia
5. Glycogen Storage Disease (Glycogenosis)

Experts

1. Unwin, Robert J: 6 articles (08/2007 - 01/2002)
2. Kleta, Robert: 5 articles (05/2006 - 08/2002)
3. Gahl, William A: 5 articles (05/2006 - 12/2003)
4. Watanabe, Toru: 5 articles (06/2005 - 01/2002)
5. Norden, Anthony G W: 5 articles (11/2004 - 01/2002)
6. Cutillas, Pedro R: 4 articles (08/2007 - 05/2003)
7. Deray, Gilbert: 3 articles (02/2009 - 05/2005)
8. van den Heuvel, Lambertus P: 3 articles (11/2008 - 11/2005)
9. Monnens, Leo A: 3 articles (11/2008 - 11/2005)
10. Levtchenko, Elena N: 3 articles (11/2008 - 11/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Fanconi Syndrome:
1. Uric Acid (Urate)IBA
2. maleic acid (maleate)IBA
3. CalciumIBA
4. PotassiumIBA
01/01/1971 - "The mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA) was investigated in 10 patients, each of whom had impaired proximal renal tubular reabsorption of bicarbonate as judged from a greater than 15-20% reduction of renal tubular bicarbonate reabsorption (THCO(3) (-)) at normal plasma bicarbonate concentrations. "
01/01/1971 - "On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA)."
03/01/1971 - "IN TWO PATIENTS WITH CLASSIC RENAL TUBULAR ACIDOSIS (RTA) AND IN TWO PATIENTS WITH RTA ASSOCIATED WITH THE FANCONI SYNDROME, RENAL POTASSIUM WASTING PERSISTED DESPITE SUSTAINED CORRECTION OF ACIDOSIS: (a) during moderate degrees of hypokalemia, daily urinary excretion of potassium exceeded 80 mEq in each patient; (b) during more severe degrees of hypokalemia, daily urinary excretion of potassium exceeded 40 mEq in two patients and 100 mEq in another. "
09/01/2005 - "Laboratory studies showed profound hypokalemia with renal potassium (K) wasting, hyperchloremic metabolic acidosis, hypophosphatemia with hyperphosphaturia, hypouricemia with hyperuricosuria, and glycosuria, consistent with Fanconi syndrome. "
03/01/1971 - "The findings provide no support for the traditional view that renal potassium wasting in either classic RTA or RTA associated with the Fanconi syndrome is predictably corrected solely by sustained correction of acidosis with alkali therapy."
Order ALL the reference details at left...
5. IfosfamideFDA LinkGeneric
6. Glucose (Dextrose)FDA LinkGeneric
7. Amino AcidsFDA Link
8. Vitamin DFDA LinkGeneric
9. ElectrolytesIBA
10. sodium phosphate (trisodium phosphate)FDA LinkGeneric

Therapies and Procedures

1. Kidney Transplantation
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)
4. Transplants (Transplant)
07/01/1995 - "Two of four recipients of marrow from presumed Fanconi syndrome heterozygotes presented with poor graft function and a third recipient developed graft failure after initial evidence of engraftment. "
07/01/1995 - "The 57 of 253 (23%) member centres which responded to the survey reported seven transplants from donors with the following conditions: Down syndrome (n = 2), suspected heterozygotes for Fanconi syndrome (n = 3), and 47,XXX syndrome (n = 2), among a total of 5,561 allogeneic transplants from HLA-identical siblings. "
07/01/1995 - "The much higher than expected incidence of graft problems with marrow from such a donor would make it reasonable to look either for an alternative marrow donor or consider an autologous transplant, in case a sibling marrow donor with Down syndrome or heterozygosity for Fanconi syndrome is encountered, although a donor with trisomy X seems acceptable."
07/01/1995 - "The experience reported here shows a low frequency of encountering an HLA-identical sibling donor who has chromosomal abnormalities in marrow cells consistent with Down syndrome or heterozygosity for Fanconi syndrome, about one case among 1,000 transplants. "
07/01/1995 - "Down syndrome or heterozygosity for Fanconi syndrome) are suitable donors for allogeneic bone marrow transplants, we have reviewed the patient files at the Fred Hutchinson Cancer Research Center (FHCRC) and carried out a survey among member centres of the International Bone Marrow Transplant Registry (IBMTR). "
Order ALL the reference details at left...
5. Transplantation (Transplant Recipients)

blog comments powered by Disqus
TREATMENT OPTIONS
for Fanconi Syndrome,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 8 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 14 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$8.50 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$45.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>